The involvement of pro-inflammatory cytokines in nephrogenic systemic fibrosis – A mechanistic hypothesis based on preclinical results from a rat model treated with gadodiamide
- 1 November 2009
- journal article
- Published by Elsevier in Experimental and Toxicologic Pathology
- Vol. 61 (6) , 537-552
- https://doi.org/10.1016/j.etp.2008.11.004
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Circulating Fibrocytes: Cellular Basis for NSFJournal of the American College of Radiology, 2008
- Gadodiamide contrast agent ‘activates’ fibroblasts: a possible cause of nephrogenic systemic fibrosisThe Journal of Pathology, 2007
- Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosisBritish Journal of Dermatology, 2007
- Gadodiamide-Associated Nephrogenic Systemic Fibrosis: Why Radiologists Should Be ConcernedAmerican Journal of Roentgenology, 2007
- Nephrogenic fibrosing dermopathy: the first 6 yearsCurrent Opinion in Rheumatology, 2003
- Osteopontin: a bridge between bone and the immune systemJournal of Clinical Investigation, 2003
- Scleromyxoedema-like cutaneous diseases in renal-dialysis patientsPublished by Elsevier ,2000
- Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and ApplicationsChemical Reviews, 1999
- Preclinical Safety Assessment and Pharmacokinetics of Gadodiamide Injection, a New Magnetic Resonance Imaging Contrast AgentInvestigative Radiology, 1993
- Tumor Necrosis Factor-Mediated Hypoalbuminemia in RabbitsJournal of Nutrition, 1988